Refresh

Remus Pharmaceuticals Ltd. - Research Center

Group () BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

63.50 45.03 24.72 18.42 11.92
Expenses

Material consumed

27.83 21.44 12.27 11.49 7.04

Manufacturing expenses

- - - - -

Personnel expenses

6.56 5.47 3.49 3.00 2.86

Selling expenses

- - - - -

Adminstrative expenses

9.06 7.57 4.89 3.17 1.63

Expenses capitalised

- - - - -

Cost of sales

43.45 34.48 20.65 17.66 11.53

Operating profit

20.04 10.55 4.07 0.76 0.39

Other recurring income

3.69 1.58 0.72 0.81 0.85

Adjusted PBDIT

23.74 12.12 4.79 1.57 1.24

Financial expenses

0.32 0.23 0.09 0.04 0.04

Depreciation

0.90 0.48 0.15 0.18 0.11

Other write offs

- - - - -

Adjusted PBT

22.52 11.41 4.55 1.36 1.09

Tax charges

5.71 2.91 1.16 0.33 0.28

Adjusted PAT

16.82 8.50 3.39 1.03 0.81

Non recurring items

- - - - -

Other non cash adjustments

- - - - -

Reported net profit

16.82 8.50 3.39 1.03 0.81

Earnigs before appropriation

30.71 14.08 6.42 3.04 2.01

Equity dividend

0.59 - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

30.12 14.08 6.42 3.04 2.01
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com